Extended Data Table 6 Adverse events leading to death in the as-treated population

From: The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

  1. *As indicated by the investigator.
  2. †Adverse events with a possible immune-mediated cause were considered regardless of attribution to study treatment by the investigator. The specific events are based on a list of terms provided by the sponsor. In addition to the specific terms listed, related terms were also included.
  3. ‡Diagnosis of myocarditis was supported by post-mortem histological findings of a CD3-positive T cell population in the lymphocytic infiltrate in the myocardium; there were no features of myocardial infarction.
Back to article page